Prof. Zvia Agur – President
Professor Zvia Agur is an internationally known biomathematician, who has made major contributions to the theory of disease dynamics, chemotherapy and vaccination policies optimization. Prof. Agur is founder of the Institute for Medical BioMathematics (IMBM), has been the president of the Israeli Society of Theoretical and Mathematical Biology, a founding member of the Board of Directors of the European Society of Mathematical and Theoretical Biology, and an editor of several professional publications. Her innovative research work has won national awards, has been published in a long line of leading scientific journals and is recognized by the academic community worldwide. In 2016 Prof. Agur was a finalist for the EU Prize for Women Innovators, by the European Commission program Horizon2020. She holds a Ph.D. from the Hebrew University in Jerusalem and the Université Libre in Brussels.
Dr. Moran Elishmereni
Moran Elishmereni has been a member of IMBM since November 2004. She holds a B.Sc. in Computational Biology from Bar-Ilan University, Israel, and a M.Sc. and PhD in Immuno-pharmacology from the Hebrew University of Jerusalem, Israel. Her PhD thesis focused on the discovery and characterization of the “Allergic Synapse”, an intricate network of interactions between mast cells and eosinophils, which boost inflammatory responses. In IMBM, Moran has taken part in various Cancer Therapy projects.
Dr. Anat Ben Yaacov
Dr. Anat Ben-Yaacov holds a PhD in Biology from the Hebrew University of Jerusalem. Her PhD thesis, under the supervision of Prof. Yael Stern-Bach, focuses on glutamate receptors, the most abundant receptors in the brain, in particular these of the AMPA- type, and their regulation by auxiliary proteins. This was achieved through the identification of the regulatory domains and protein-protein interfaces, employing methods of electrophysiology, biochemistry, and microscopy. Anat has also completed her post-doctoral research in the Cancer Research Center in Sheba Hospital and Tel-Aviv University. Her research topic dealt primarily with RNA modifications and regulation of gene expression. Anat joined IMBM in August 2019. At IMBM she provides biological input to various projects. Currently she is a collaborator in the Intensive Care Unit (ICU) project.
Yuri Kogan holds a BA degree in Theoretical Mathematics from the Tel-Aviv University (TAU). Over many years of scientific research at IMBM (since 1999), Yuri has been involved in biomathematical modelling of several cancer diseases, as well as in the research of cancer stem cells, intracellular signal transduction and clinical immunotherapy. His current research continues to focus on modelling cancer growth and treatment, in particular, immunotherapy of prostate cancer and melanoma, with a particular emphasis on using population and mixed-effects approach to model clinical data. Additional areas of interest include modelling of immune memory and of intracellular signal transduction.
Avi Gillis joined IMBM in 2018. He obtained his B.Sc. in Applied Mathematics from Bar-Ilan University in 2015, and is currently in the middle of post-graduate studies in Theoretical Mathematics at Tel-Aviv University.
Dr. Dorit Shemesh
Dorit Shemesh joined IMBM in 2020. Dorit obtained a B.Sc. in Chemistry with distinction at the Hebrew University of Jerusalem, and a Ph.D. in Theoretical Chemistry from the Hebrew University of Jerusalem under the supervision of Prof. Benny Gerber. In her Ph.D. she studied photoionization dynamics of biological molecules. In her PostDoc at the Technische Universität München working with Prof. Domcke she was introduced to photostability of biological molecules, until then only known to exist in nucleic acids. She contributed to this field, by showing for the first time that peptides exhibit a radiationless deactivation pathway that prevent them from undergoing structural damage. In the last decade she worked as a Research Associate at the Hebrew University focusing on photoabsorption and photodynamics of atmospherically relevant molecules, such as pesticides, aldehydes and organic acids. Currently she is involved in the Intensive Care Unit (ICU) Project.
Dorit Dror is the Administrative Manager of IMBM. She holds a B.A. degree in English Literature and Information Science from Bar-Ilan University. Her primary responsibility in IMBM is providing quality services to ensure successful finance and personnel management of IMBM’s scientific and administrative members and visitors the latter include Israeli and foreign scientists and students, engineering trainees, as well as post-doctorate students at IMBM. In her work she also maintains IMBM’s information center, builds data retrieval applications and is in charge of the institute’ Internet site. As the administrator of IMBM, a non-profit organization, Dorit is also in charge of IMBM’s “Amutah”, organizing board meetings, preparing board minutes, and presenting budget and annual reports to the organization’s lawyers and accountants. She organizes and oversees the logistical activities in the office, procurement activities and staff workload oversight